[{"NetIncomeLoss_1_Q2_USD":-26724000.0,"InterestIncomeOther_1_Q2_USD":998000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":8565000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":631000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":67263000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":31407000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":138019000.0,"Depreciation_2_Q2_USD":1724000.0,"PaymentsToAcquireInvestments_2_Q2_USD":71103000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2500266.0,"AssetsCurrent_0_Q2_USD":315865000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":537781000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":67645441.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":67645441.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":367000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_2_Q2_USD":20369.0,"CommonStockSharesIssued_0_Q2_shares":4883208.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":175153000.0,"Assets_0_Q2_USD":348035000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":306000.0,"InterestIncomeOther_2_Q2_USD":2570000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":4408470.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":4281169.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":5.05,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-1061000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":4451000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":2567000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":995000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":258000.0,"RestrictedCash_0_Q2_USD":878000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_2_Q2_USD":306000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q2_USD":-763000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-763000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-51304000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-4045000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":137053000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":22872000.0,"Liabilities_0_Q2_USD":35646000.0,"Investments_0_Q2_USD":175153000.0,"DeferredCosts_0_Q2_USD":1123000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":4.35,"GeneralAndAdministrativeExpense_2_Q2_USD":10814000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6053000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-27487000.0,"UnrealizedGainLossOnInvestments_1_Q2_USD":-763000.0,"ShareBasedCompensation_2_Q2_USD":5487000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":22778000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":438000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":7471087.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":1428137.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-241092000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":95099000.0,"CommonStockSharesOutstanding_0_Q2_shares":4592731.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":631000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4032000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-43178000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":174522000.0,"LiabilitiesCurrent_0_Q2_USD":12765000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":137931000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3659000.0,"AdditionalPaidInCapital_0_Q2_USD":15064000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":181414.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":330000.0,"ProceedsFromSaleAndMaturityOfOtherInvestments_2_Q2_USD":210556000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":13865000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":7391000.0,"NetIncomeLoss_2_Q2_USD":-51610000.0,"AccountsPayableCurrent_0_Q2_USD":2830000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":21666000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1434000.0,"DeferredOfferingCosts_0_Q2_USD":1123000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.93,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":718000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":260000000.0,"CommonStockValueOutstanding_0_Q2_USD":5000.0,"OperatingIncomeLoss_2_Q2_USD":-54177000.0,"OperatingIncomeLoss_1_Q2_USD":-27719000.0,"OtherNonoperatingExpense_2_Q2_USD":3000.0,"OtherNonoperatingExpense_1_Q2_USD":3000.0,"StockholdersEquity_0_Q2_USD":-225392000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.89,"LiabilitiesAndStockholdersEquity_0_Q2_USD":348035000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":5487000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4032000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":153941.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1370000.0,"OperatingExpenses_2_Q2_USD":54177000.0,"OperatingExpenses_1_Q2_USD":27719000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-12.06,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-6.06,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.95,"ResearchAndDevelopmentExpense_2_Q2_USD":43363000.0,"Ticker":"RLAY","CIK":"1812364","name":"RELAY THERAPEUTICS, INC.","OfficialName":"Relay Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3171086334.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200827"}]